XML 40 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock Option Plans
9 Months Ended
Sep. 30, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Plans

NOTE – 5 Stock Option Plans

A summary of option activity for employees under the plans and changes during the nine months ended September 30, 2015, is presented below:

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

Number

 

 

Averaged

 

 

Remaining

 

 

Intrinsic

 

 

 

of

 

 

Exercise

 

 

Contractual

 

 

Options

 

 

 

Options

 

 

Price $

 

 

Life (Years)

 

 

Value $

 

Outstanding, January 1, 2015

 

 

1,472,130

 

 

 

1.33

 

 

 

3.23

 

 

 

1,430,231

 

Granted

 

 

157,306

 

 

 

3.01

 

 

 

4.48

 

 

 

57,000

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, September 30, 2015

 

 

1,629,436

 

 

 

1.49

 

 

 

2.50

 

 

 

2,620,771

 

Exercisable,  September 30, 2015

 

 

1,077,520

 

 

 

1.14

 

 

 

1.95

 

 

 

2,093,571

 

 

Milestone Scientific recognizes stock compensation expense on a straight line basis over the requisite service period. During the three months ended September 30, 2015, and 2014 Milestone Scientific recognized $107,205 and $39,877 of total stock compensation cost. During the nine months ended September 30, 2015 and 2014, Milestone Scientific recognized $334,049 and $119,630 of total stock compensation cost. As of September 30, 2015 and September 30, 2014, there was $881,765 and $272,946, respectively, of total unrecognized compensation cost related to non-vested options which Milestone Scientific expects to recognize over a weighted average period of 3.59 years and 2.0 years at September 30, 2015 and 2014, respectively. A 6%  rate of forfeitures is assumed in the calculation of the compensation cost for the period in 2015 and 2014.

Expected volatilities are based on historical volatility of Milestone Scientific’s common stock over a period commensurate with the anticipated term. Milestone Scientific uses historical data to estimate option exercise and employee termination within the valuation model.

A summary of option activity for non-employees under the plans and changes during the nine months ended September 30, 2015, is presented below:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

Number

 

 

Averaged

 

 

Remaining

 

 

Intrinsic

 

 

 

of

 

 

Exercise

 

 

Contractual

 

 

Options

 

 

 

Options

 

 

Price $

 

 

Life (Years)

 

 

Value $

 

Outstanding, January 1, 2015

 

 

16,666

 

 

 

1.27

 

 

 

0.62

 

 

 

17,166

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

8,333

 

 

 

1.53

 

 

 

 

 

 

 

Outstanding, September 30, 2015

 

 

8,333

 

 

 

1.01

 

 

 

0.19

 

 

 

17,166

 

Exercisable, September 30, 2015

 

 

8,333

 

 

 

1.01

 

 

 

0.19

 

 

 

17,166

 

 

During the nine months ended September 30, 2015 and September 30, 2014, Milestone Scientific had no expenses related to non-employee options that vested during the period. There was no unrecognized compensation cost related to non-vested options as of September 30, 2015. A six percent rate of forfeitures is assumed in the calculation of the compensation cost for the period.

In accordance with the provisions of FASB ASC 505-50-15, all other issuances of common stock, stock options or other equity instruments to non-employees as consideration for goods or services received by Milestone Scientific are accounted for based on the fair value of the equity instruments issued (unless the fair value of the consideration received can be more reliably measured). The fair value of any options or similar equity instruments issued is estimated based on the Black-Scholes option-pricing model and the assumption that all of the options or other equity instruments will ultimately vest. Such fair value is measured as of an appropriate date pursuant to the guidance, (generally, the earlier of the date the other party becomes committed to provide goods or services or the date of performance by the other party is complete) and capitalized or expensed as if Milestone Scientific had paid cash for the goods or services.